A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.

BJU International
Mary-Ellen TaplinSteven P Balk

Abstract

To evaluate mifepristone (RU-486) in patients with castration-resistant prostate cancer (CRPC), with a correlative assessment of serum androgens and androgen metabolites The androgen receptor (AR) is critical in the development and progression of prostate cancer, but available antiandrogens incompletely abrogate AR signalling. Mifepristone is a potent AR antagonist that functions by competing with androgen, preventing AR coactivator binding and by enhancing binding of AR corepressors. Patients with CRPC were treated with mifepristone 200 mg/day oral until disease progression. Testosterone, dihydrotestosterone (DHT), androstenedione, dihydroepiandrosterone sulphate and the testosterone metabolite 3 alpha-diol G, were measured at baseline and during therapy. Nineteen patients were enrolled between April and August 2005; they were treated for a median (range) of 85 (31-338) days. The median prostate-specific antigen (PSA) level at enrollment was 22.0 (3.0-937.2) ng/mL. No patient had a PSA response (>50% reduction in PSA). Six patients had stable disease for a median of 5.5 months. After 1 month, adrenal androgens were increased and testosterone and DHT increased by 91% and 80%, respectively, compared to baseline. Mifepristone had...Continue Reading

References

Jun 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·S W LambertsH de Jong
Jan 1, 1974·Annals of Surgery·T BhanalaphG P Murphy
May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
Jan 1, 1997·Annual Review of Medicine·F CadepondE E Baulieu
Apr 5, 2002·Molecular Cell·Yongfeng ShangMyles Brown
May 17, 2002·The Journal of Biological Chemistry·David MasielloSteven P Balk
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·G J C M KolvenbagG R P Blackledge
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James L MohlerFrank S French
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tsutomu NishiyamaKota Takahashi
Mar 11, 2005·Expert Review of Anticancer Therapy·Scott M Dehm, Donald J Tindall
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mark A TitusJames L Mohler
Nov 10, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I Scher, Charles L Sawyers
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Nupam P MahajanYoung E Whang

❮ Previous
Next ❯

Citations

Aug 10, 2011·Nature Reviews. Clinical Oncology·Timothy A YapJohann S de Bono
Jul 16, 2009·Current Opinion in Obstetrics & Gynecology·Irving M Spitz
Oct 15, 2008·Molecular Cancer Therapeutics·Myles C HodgsonSteven P Balk
Jul 6, 2014·Asian Journal of Andrology·Oliver SartorJohann de Bono
Jan 28, 2010·Expert Opinion on Pharmacotherapy·Annie Im, Leonard J Appleman
Aug 28, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Naohiro Fujimoto
Jul 24, 2012·The Journal of Urology·Martin LigrPeng Lee
Mar 15, 2012·Molecular and Cellular Endocrinology·Nathalie Chabbert-BuffetPhilippe Bouchard
Oct 1, 2011·Clinical Genitourinary Cancer·Mari NakabayashiMary-Ellen Taplin
May 16, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Jennifer A LockeEmma S Tomlinson Guns
Jan 14, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Anne ØrboRuth H Paulssen
Nov 14, 2015·Nature Reviews. Cancer·Philip A WatsonCharles L Sawyers
Oct 21, 2015·Endocrine-related Cancer·Jan KroonGabri van der Pluijm
Nov 15, 2015·Journal of Hematology & Oncology·Michael T Schweizer, Evan Y Yu
Sep 30, 2016·Reproductive Sciences·Joana FeiteiroElisa Cairrão
Sep 2, 2008·Expert Review of Anticancer Therapy·Mary-Ellen Taplin
Mar 5, 2013·Pharmacological Reviews·Thomas P BurrisDouglas J Kojetin
Apr 4, 2009·Current Opinion in Urology·Eliezer M Van Allen, Charles J Ryan
Jan 11, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joo Hyoung LeeSelvarangan Ponnazhagan
Sep 6, 2018·Genes & Development·Guocan WangRonald A DePinho
Jul 5, 2017·BMC Cancer·Delores J GrantStephen J Freedland
Jun 6, 2018·Frontiers in Physiology·Beste TuranliAdil Mardinoglu
May 22, 2019·International Journal of Molecular Sciences·Fiona M Frame, Norman J Maitland
Apr 22, 2017·Molecular Cancer Therapeutics·Jacob KachRussell Z Szmulewitz
Apr 1, 2017·Cancer Research·Alexis A KurmisPeter B Dervan
Nov 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin PuhrHelmut Klocker
Mar 9, 2021·Frontiers in Oncology·Monserrat Llaguno-MunivePatricia Garcia-Lopez
Sep 17, 2021·Nature Reviews. Urology·Gaëtan DevosSteven Joniau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC
Executive Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC)
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Sheila Dunn, Melissa Brooks
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC
Executive Committee of the Society of Obstetricians and Gynaecologists of Canada (SOGC)
© 2022 Meta ULC. All rights reserved